Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C36H30O16 |
Molecular Weight | 718.6152 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
c1cc(c(cc1C[C@]([H])(C(=O)O)OC(=O)/C(/[H])=C(\[H])/c2ccc(c3c2[C@@]([H])([C@@]([H])(c4ccc(c(c4)O)O)O3)C(=O)O[C@]([H])(Cc5ccc(c(c5)O)O)C(=O)O)O)O)O
InChI
InChIKey=SNKFFCBZYFGCQN-VWUOOIFGSA-N
InChI=1S/C36H30O16/c37-20-6-1-16(11-24(20)41)13-27(34(45)46)50-29(44)10-5-18-3-9-23(40)33-30(18)31(32(52-33)19-4-8-22(39)26(43)15-19)36(49)51-28(35(47)48)14-17-2-7-21(38)25(42)12-17/h1-12,15,27-28,31-32,37-43H,13-14H2,(H,45,46)(H,47,48)/b10-5+/t27-,28-,31+,32-/m1/s1
Molecular Formula | C36H30O16 |
Molecular Weight | 718.6152 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.hindawi.com/journals/ecam/2013/759483/
Sources: https://www.hindawi.com/journals/ecam/2013/759483/
Salvianolic acid B is a bioactive molecule isolated from Radix Salviae Miltiorrhizae. The compound shows high antioxidant and free radical scavenging activities. It is a major component of the commercial Fufang Danshen products (Compound Danshen Dripping Pill, the Danshen Pian, and the Danshen Injection, ICP), used for the treatment of angina pectoris, and other heart diseases.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27002395
Curator's Comment:: The drug may protect CNS from degenerative processes.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Effects of salvianolic acid B on expressions of TGF-beta1 and its receptors in liver of rats with dimethylnitrosamine-induced hepatic fibrosis]. | 2005 Jul |
|
In vitro anti-fibrotic activities of herbal compounds and herbs. | 2009 Oct |
|
Salvianolic acid B protects SH-SY5Y neuroblastoma cells from 1-methyl-4-phenylpyridinium-induced apoptosis. | 2010 |
|
Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats. | 2010 Jan 15 |
|
Salvianolic acid B inhibits the TLR4-NFκB-TNFα pathway and attenuates neonatal rat cardiomyocyte injury induced by lipopolysaccharide. | 2011 Oct |
|
Direct stimulation of adult neural stem/progenitor cells in vitro and neurogenesis in vivo by salvianolic acid B. | 2012 |
|
Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway. | 2013 Feb 4 |
|
Salvianolic acid B protects against acute ethanol-induced liver injury through SIRT1-mediated deacetylation of p53 in rats. | 2014 Jul 15 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.taslyint.com/show-68-208-1.html
Oral or sublingual application, 2 capsules (ICP) each time, 1 to 2 times daily before meals. Sublingual administration of all the pills from inside the capsule to relieve acute angina pectoris.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23840250
When salvianolic acid B concentration is 2.5, 5, and 10 mg/l, cell viability, and superoxide dismutase (SOD) activity are enhanced, and the formation of malondialdehyde (MDA) in human umbilical vein endothelial cells (ECV304) is inhibited.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 03:15:27 UTC 2021
by
admin
on
Sat Jun 26 03:15:27 UTC 2021
|
Record UNII |
C1GQ844199
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1609818
Created by
admin on Sat Jun 26 03:15:27 UTC 2021 , Edited by admin on Sat Jun 26 03:15:27 UTC 2021
|
PRIMARY | USP-RS | ||
|
C1GQ844199
Created by
admin on Sat Jun 26 03:15:27 UTC 2021 , Edited by admin on Sat Jun 26 03:15:27 UTC 2021
|
PRIMARY | |||
|
121521-90-2
Created by
admin on Sat Jun 26 03:15:27 UTC 2021 , Edited by admin on Sat Jun 26 03:15:27 UTC 2021
|
PRIMARY | |||
|
6451084
Created by
admin on Sat Jun 26 03:15:27 UTC 2021 , Edited by admin on Sat Jun 26 03:15:27 UTC 2021
|
PRIMARY | |||
|
SUB130514
Created by
admin on Sat Jun 26 03:15:27 UTC 2021 , Edited by admin on Sat Jun 26 03:15:27 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |